Gluckman, those are some of the reasons this research is so important
Zone 5: Under-eye and tear trough Per the Ridha 2024 paper (PMID 38874170), the sub-orbicularis oculi fat (SOOF) compartment is among the most affected by GLP-1 weight loss
Don't wait for a patient portal response for any of these
Patients treated with semaglutide commonly experience weight reductions averaging 10% to 15% of their total body weight, significantly outperforming the 5% to 7% reduction typically seen with liraglutide
Milicevic Z, Cell Metabolism (Vol 34, Issue 9, Sept 6, 2022, pp 12341247.e9)
Medications known as GLP-1 agonists are used in the management of diabetes to enhance these beneficial effects and improve blood sugar control